Index by author
May 1, 2018; Volume 59,Issue 5
Aulmann, Christoph
- You have accessPredictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with VandetanibRudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin LapaJournal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
Bardies, Manuel
- You have accessPSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe HaberkornJournal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993
Bathen, Tone F.
- You have accessCombined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate CancerMattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. BathenJournal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598
Baum, Richard P.
- You have access177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical ResultsRichard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane SmerlingJournal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847
Bertilsson, Helena
- You have accessCombined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate CancerMattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. BathenJournal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598
Binse, Ina
- You have accessRadioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary MalignancyMark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. KimJournal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359
Boerman, Otto C.
- You have accessDigitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid CancerMarika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. PlantingaJournal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675
Bozin, Michael
- You have access18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual InterpretationDavid A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita SkandarajahJournal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085
Broski, Stephen M.
- You have access18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation BiomarkerJason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. BroskiJournal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741
Brouwers, Adrienne H.
- You have accessMolecular Imaging in Cancer Drug DevelopmentStijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de VriesJournal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045